Samsung Biologics hosted an on-demand webinar featuring Jeffrey Mason, VP, Head of US Sales, discussing standardized operations, digitalization, and multi-plant sourcing for scalable manufacturing and supply flexibility.
Public source
Publisher name
Public post
In biologics manufacturing, flexibility doesn’t have to come at the expense of standardization. In fact, standardization can be what makes flexibility possible at scale.…
Company
Samsung Biologics
Innovation, passion and an unwavering dedication to find breakthrough solutions in biomedicines.
- Industry
- Pharmaceutical Manufacturing
- Location
- Songdo, KR
- Company size
- 1,001–5,000 employees
About Samsung Biologics
Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide.
See moreLatest activity
Latest activity from Samsung Biologics
9 signals
Research & Knowledge
Samsung Biologics published an infographic exploring how the company approaches antibody production, conjugation, and ADC challenges through large-scale manufacturing experience, dedicated bioconjugation infrastructure, process optimization, and analytical data showing consistent DAR distribution across development and pilot scales.
Presence & Recognition
Samsung Biologics VP of Antibody Cell Purification Process Development Taeheui Lee participated in the BPI2026 conference in Boston on Wednesday, September 23, 2026, discussing real-world case studies across diverse molecular formats and an integrated risk-based CMC approach.
Research & Knowledge
Samsung Biologics published a video explaining how selective intensification using N-1 perfusion enhances fed-batch productivity, achieving higher seeding density, VCD, and protein output while maintaining fed-batch.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Patheon
Patheon featured Jennifer Cannon, Sector Commercial President, BioPharma Services, in a webinar hosted by Life Science Connect discussing onshoring strategies and flexible manufacturing models.
Presence & Recognition
Upperton Pharma Solutions
Upperton Pharma Solutions held a webinar on sterile drug products on-demand on September 1, 2026.
Presence & Recognition
Asymchem Group
Asymchem Group hosted an upcoming webinar hosted by subsidiary AsymBio on biologics and ADC development strategies
Presence & Recognition
Bora Biologics
Bora Biologics is attending two upcoming industry events, BioProcess International on October 22–25, 2026, at the Hynes Convention Center in Boston, and Contract Pharma on October 24–25, 2026, at the Hyatt Regency in New Brunswick, NJ, to discuss biologics manufacturing strategy.
Presence & Recognition
LOTTE Biologics